Electrotransport delivery device
US6090095A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 24, 1997 |
| Grant date | Jul 18, 2000 |
| Priority date | — |
| Expiry date | Jun 24, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/303
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An electrotransport delivery device (410) includes control circuitry for discontinuously delivering a beneficial agent (eg, a drug) through a body surface (eg, skin 400). For example, the device may be the type which is manually activated by the patient or other medical personnel to activate electrotransport drug delivery. Once electrotransport delivery has been activated, a timer (221) counts a transition interval, typically about one minute, during which the device is allowed to operate and the impedance of the body surface (400) is allowed to stabilize. Thereafter, the electrotransport current and voltage are then monitored and compared to predetermined limits. Allowing for the transition interval permits tighter tolerances in monitoring the applied current.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.